Clinical Trial

Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to find a new radioimmunotherapy regimen for advanced malignancies with multiple metastatic after standard treatment failure/drug resistance. The main questions it aims to answer is: the safety and efficacy of the new regimen for advanced multiple metastatic solid tumors standard treatment failure/drug resistance, and explore the impact on immune function. Participants will receive the combination of radiotherapy and immunotherapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-12-07; most recent amendment 2025-02-25.
Status change: Not Yet Recruiting → Recruiting 2023-12-17
Trial Details
NCT Number NCT06173219
Lead Sponsor China-Japan Friendship Hospital
Conditions Advanced Solid Tumor
Enrollment 38 participants
Start Date 2025-08-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-27